Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

NHS to study effect of aspirin on cancer and SNP must change tack on NHS

A round-up of the morning’s health news headlines

The NHS is to fund a major study into the effects of taking daily aspirin on the recurrence of common bowel, breast, oesophageal, prostate or stomach cancers.

The Guardian reports that study will be jointly funded by the health service and Cancer Research UK and will involve 11,000 patients across 100 UK centres, following them for up to 12 years.

Prof Ruth Langley, the chief investigator at the Medical Research Council’s clinical trials unit at University College London, said: ‘If we find that aspirin does stop these cancers returning, it could change future treatment.’

And finally, the Scottish National Party must make ‘fundamental changes’ in its approach to the NHS to avoid a collapse in health care quality, according to Audit Scotland.

The Independent reports that waiting times have ‘deteriorated’ under the SNP and the party has presided over 0.7% real-terms cut to the health budget since 2008/09.

But Scottish health secretary Shona Robinson said Scotland had a record high workforce and ‘had delivered… some of the highest quality and safest healthcare anywhere in the world.’

Have your say

IMPORTANT: On Wednesday 7 December 2016, we implemented a new log in system, and if you have not updated your details you may experience difficulties logging in. Update your details here. Only GMC-registered doctors are able to comment on this site.